|
WO2015108134A1
|
|
Glut4 endocytosis inhibitor
|
|
WO2015105094A1
|
|
Agent for treating diabetes
|
|
EP3085376A1
|
|
Anti-cancer agent
|
|
WO2015056675A1
|
|
Antidepressant combination drug
|
|
EP2997967A1
|
|
Cell membrane transport promoter for selective 5-ht1a serotonin receptors
|
|
EP2982370A1
|
|
Elastin synthesis/regeneration promoting agent
|
|
US2016008308A1
|
|
Inhibitor of τ protein phosphorylation
|
|
US2015376213A1
|
|
Phospholipid compound containing unsaturated fatty acid derivative having cyclopropane ring
|
|
WO2012090713A1
|
|
Concomitant drug for improving cognitive function
|
|
WO2012067111A1
|
|
PKC-ε ACTIVATOR
|
